Sign In
NewsRadar

Press release centre

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.
   

Past Press Releases - PolyTherics, Ltd.

May 15, 2012
New Board Members join PolyTherics
ENHANCED BREADTH OF EXPERIENCE ON POLYTHERICS’ BOARD SUPPORTS NEXT PHASE OF DEVELOPMENT More

December 6, 2010
PolyTherics and MacroGenics sign collaboration agreement
PolyTherics Ltd, an innovator in precision engineering of proteins to improve their pharmacokinetic properties, today announced the initiation of a research collaboration with MacroGenics Inc., a leader in next-generation antibody platforms and therapeutics. More

September 7, 2010
PolyTherics moves lead candidate into development and manufacturing with DSM BioSolutions
DSM BioSolutions, DSM’s microbial fermentation CMO business unit and PolyTherics, an innovator in precision engineering of proteins, today announced that they have entered into an agreement for the process development and manufacture of PolyTherics’ lead biobetter product, HiPEG IFN α-2a. More

June 16, 2008
PolyTherics Ltd and Alligator Bioscience AB announce strategic collaboration for optimisation of nex
London, UK, and Lund, Sweden, 16 June 2008. PolyTherics Ltd (“PolyTherics”), a biopharmaceutical company specialised in the targeted application of polymers to biopharmaceuticals, and Alligator Bioscience AB (“Alligator”), a biotechnology company applying proprietary technology to the improvement of proteins, today announced the establishment of a new alliance. More

May 27, 2008
Novel approach to drug insolubility strengthens PolyTherics patent estate
Polytherics Ltd (“PolyTherics”), a biopharmaceutical spin-out company from Imperial College London and the London School of Pharmacy that specialises in the targeted application of polymers to biopharmaceuticals, today announced the grant of a European patent on the application of polymer complexation technology to improve drug efficacy. More

March 4, 2008
PolyTherics expands Collaboration with Biocompatibles and grants Option for
PolyTherics Ltd (“PolyTherics”), a biopharmaceutical spin-out company from Imperial College London and the London School of Pharmacy that specialises in the targeted application of polymers to biopharmaceuticals, today announced the expansion of its collaboration with Biocompatibles International plc (“Biocompatibles”), a leading medical technology company in the field of drug device combination products. More

February 26, 2008
PolyTherics and Celtic Pharma sign Collaboration Agreement to explore technologies for improved drug
PolyTherics Limited (“PolyTherics”), a biopharmaceutical spin-out company from Imperial College London and the London School of Pharmacy, and Celtic Pharma Development Services Bermuda Ltd (“Celtic Pharma”), a subsidiary of Celtic Pharmaceutical Holdings LP, a global private equity investment fund focused on the biopharma industry, today announced that they have entered into a broad research collaboration agreement. More

February 12, 2008
New Consortium announces Significant Grant Funding of Anaemia product programme
GlycoForm Ltd, PolyTherics Ltd, and Aston University today announced that they have been awarded prestigious grants totalling £685,000 from the Technology Strategy Board and Biotechnology and Biological Sciences Research Council. More

November 26, 2007
Innovative Drug Production Project secures funding from Technology Strategy Board
PolyTherics, a biopharmaceutical spin-out company from Imperial College London and the London School of Pharmacy, today announced that it has secured £350,000 in funding from the Technology Strategy Board. More

August 7, 2007
PolyTherics and BioVectra dcl sign Manufacturing and Representation Deal
PolyTherics, a biopharmaceutical spin-out company from Imperial College London and the London School of Pharmacy, today announced that it has signed a manufacturing and bilateral representation agreement with BioVectra dcl, a Canadian biopharmaceutical company that supplies specialty chemicals and contract manufacturing services to the pharmaceutical and biotechnology industry. More

Data


26,126
Tech investments
From our Online Data Service
16,881
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Sep 13N/AEnergy related
Sep 13€12.6MConsumer electronics
Sep 12€39.0MBiopharmaceuticals
Sep 12€2.3MInternet commerce
Sep 12€2.1MInternet services
Sep 12€4.0MMedical devices
Sep 12€9.0MSoftware development

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


May 28
Identiq
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
Nethone
nethone raised over $1 million from innovation nest

Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

Jan 2
Urban Jungle
urban jungle raises £1m in seed funding to build tech-enabled home ...





About usContact usLegal Information
Copyright © 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.